Literature DB >> 10800762

Sequential administration of arginine and arginine plus GHRH to test somatotroph function in short children.

J Bellone1, G Aimaretti, S Bellone, C Baffoni, G Corneli, C Origlia, M Cappa, E Ghigo.   

Abstract

The hormonal diagnosis of GH deficiency in childhood is conventionally based on the GH response to at least two provocative stimuli. Among these, arginine (ARG) has long been considered a classical, centrally mediated stimulus of GH secretion. ARG is also able to potentiate the GH response to GHRH, likely inhibiting hypothalamic somatostatin; this combined test is one of the most potent to explore the maximal secretory capacity of somatotroph cells. Based on these premises, we verified whether the sequential administration of ARG and ARG+GHRH could be feasible as single step provocative test to evaluate the GH releasable pool in short children. To this goal, 48 normal short children (35 M and 13 F, 12.0+/-0.4 yr, PS 1: 255 II-IV: 23) underwent a test with ARG (0.5 g/kg i.v. from 0 to +30 min) followed by a coadministration of ARG (from +120 to 150 min) plus GHRH (1 microg/kg i.v. at +120 min). ARG alone elicited a clear GH response (mean peak vs baseline: 12.1+/-1.7 vs 2.0+/-0.4 microg/l, p<0.001, Cmax range 12-51.0 microg/l). Following this GH rise, the hormonal levels at +120 min approached to baseline levels (4.2+/-0.8 microg/l) but then showed marked response to the coadministration of ARG+GHRH. The GH peak following ARG+GHRH (mean peak: 47.8+/-3.3 microg/l, p<0.001; Cmax 22.4-150.0 microg/l) was clearly higher (p<0.001) than that recorded after ARG alone. The GH responses to both ARG and ARG+GHRH were independent of gender, puberty, height velocity, body mass index (BMI) and IGF-I levels. Nine normal short children (16%) had GH peaks lower than 7 microg/l after ARG alone, while none showed GH peak below 20 microg/l after ARG+GHRH. Thus, ARG alone is a good stimulus of GH secretion but false positive responses frequently occur in normal short children. ARG+GHRH is a more potent stimulus giving no false positive responses even after previous challenge with ARG alone. Testing with sequential administration of ARG and ARG+GHRH may allow the single step evaluation of the somatotroph response to central and pituitary stimuli in short children.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10800762     DOI: 10.1007/BF03343686

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  19 in total

Review 1.  The diagnosis of growth hormone deficiency in children and adults.

Authors:  S M Shalet; A Toogood; A Rahim; B M Brennan
Journal:  Endocr Rev       Date:  1998-04       Impact factor: 19.871

2.  Acute administration of recombinant human growth hormone inhibits the somatotrope responsiveness to growth hormone-releasing hormone in childhood.

Authors:  J Bellone; G Aimaretti; M R Valetto; S Bellone; C Baffoni; E Arvat; S Seminara; F Camanni; E Ghigo
Journal:  Eur J Endocrinol       Date:  1996-10       Impact factor: 6.664

3.  A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.

Authors:  E Ghigo; E Imperiale; G M Boffano; E Mazza; J Bellone; E Arvat; M Procopio; S Goffi; A Barreca; P Chiabotto
Journal:  J Endocrinol Invest       Date:  1990-04       Impact factor: 4.256

4.  Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man.

Authors:  E Ghigo; S Goffi; M Nicolosi; E Arvat; F Valente; E Mazza; M C Ghigo; F Camanni
Journal:  J Clin Endocrinol Metab       Date:  1990-12       Impact factor: 5.958

5.  Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.

Authors:  E Ghigo; J Bellone; G Aimaretti; S Bellone; S Loche; M Cappa; E Bartolotta; F Dammacco; F Camanni
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

6.  Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan.

Authors:  M R Valetto; J Bellone; C Baffoni; P Savio; G Aimaretti; L Gianotti; E Arvat; F Camanni; E Ghigo
Journal:  Eur J Endocrinol       Date:  1996-11       Impact factor: 6.664

7.  Do short children secrete insufficient growth hormone?

Authors:  Z Zadik; S A Chalew; S Raiti; A A Kowarski
Journal:  Pediatrics       Date:  1985-09       Impact factor: 7.124

8.  Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion.

Authors:  B B Bercu; D Shulman; A W Root; B E Spiliotis
Journal:  J Clin Endocrinol Metab       Date:  1986-09       Impact factor: 5.958

9.  Analyses of 24-hour growth hormone profiles in children: relation to growth.

Authors:  K Albertsson-Wikland; S Rosberg
Journal:  J Clin Endocrinol Metab       Date:  1988-09       Impact factor: 5.958

10.  Variability of growth hormone response to pharmacological and sleep tests performed twice in short children.

Authors:  P Tassoni; E Cacciari; M Cau; C Colli; M Tosi; S Zucchini; A Cicognani; P Pirazzoli; S Salardi; A Balsamo
Journal:  J Clin Endocrinol Metab       Date:  1990-07       Impact factor: 5.958

View more
  6 in total

1.  Evaluation of growth hormone response to GHRH plus arginine test in children with idiopathic short stature: role of peak time.

Authors:  M Castagno; A Monzani; S Zanetta; G Genoni; E Giglione; R Ricotti; G Bona; F Prodam; S Bellone
Journal:  J Endocrinol Invest       Date:  2018-02-08       Impact factor: 4.256

2.  Impairment of GH secretion in adults with primary empty sella.

Authors:  M Gasperi; G Aimaretti; E Cecconi; A Colao; C Di Somma; S Cannavò; C Baffoni; M Cosottini; L Curtò; F Trimarchi; G Lombardi; L Grasso; E Ghigo; E Martino
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

3.  Early retesting by GHRH + arginine test shows normal GH response in most children with idiopathic GH deficiency.

Authors:  C Bizzarri; S Pedicelli; B Boscherini; G Bedogni; M Cappa; S Cianfarani
Journal:  J Endocrinol Invest       Date:  2014-11-07       Impact factor: 4.256

4.  Unreliability of classic provocative tests for the diagnosis of growth hormone deficiency.

Authors:  A Mazzola; C Meazza; P Travaglino; S Pagani; D Frattini; E Bozzola; G Corneli; G Aimaretti; M Bozzola
Journal:  J Endocrinol Invest       Date:  2008-02       Impact factor: 4.256

5.  Short children with familial short stature show enhancement of somatotroph secretion but normal IGF-I levels.

Authors:  S Bellone; G Corneli; J Bellone; C Baffoni; S Rovere; C de Sanctis; G Bona; E Ghigo; G Aimaretti
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 5.467

6.  Growth Hormone (GH) Therapy During the Transition Period: Should We Think About Early Retesting in Patients with Idiopathic and Isolated GH Deficiency?

Authors:  Laura Penta; Marta Cofini; Laura Lucchetti; Letizia Zenzeri; Alberto Leonardi; Lucia Lanciotti; Daniela Galeazzi; Alberto Verrotti; Susanna Esposito
Journal:  Int J Environ Res Public Health       Date:  2019-01-23       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.